WHO
REGULATORY UPDATE
Mylan’s Bedaquiline 100mg tablet prequalified
Published: 5/8/2026Detected: 4/10/2026
Summary preview
Adds Mylan’s bedaquiline fumarate 100 mg tablet (TB408, INDIA) to the WHO Prequalified list, enabling eligible countries/programs to procure a WHO-prequalified version for tuberculosis treatment.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
clinical
safety
labeling
#WHO prequalification
#PQT
#bedaquiline
#tuberculosis
#solid oral dosage form
Official Source Document Source Verified
Access the original document directly from WHO.